While some peptides like semaglutide (a GLP-1 receptor agonist) have FDA approval for weight loss, others are available only through off-label use or experimental stages
Given the high prevalence of both diabetes and dementia in aging populations, this strategy may reduce long-term public health burdens, including healthcare costs, caregiver stress, and institutionalization needs. Szu-Yuan Wu, MD, MPH, PhD The researcher team also discovered that study participants taking GLP-1 agonists had a 25% lower risk of developing non-vascular dementias and a 12% lower chance of developing Alzheimers disease, compared to participants taking metformin
MedComm 5(3):e497 Karunarathna I et al (2024) Glutathione for skin lightening: a review of efficacy, safety, and clinical evidence
Then false discovery rates (FDR) were calculated for metabolites by the q-value R package (50)
According to official prescribing information, Wegovy can slow stomach emptying and affect how some oral medicines move through the stomach
B12 Lipo shots help it run faster